Total Funding
76
43
Total FundingCorporate Round raised
Growth Score
-7 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
21669
Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.
- Michael C. Milone: Co-Founder, Co-Chairman of Scientific Advisory Board
- Bryan Kim: Co-Founder and CEOPast Role: Transcure Bio Ventures, CEO / Founder
HLB Group
About the Company
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T cells without triggering the T-cell exhaustion for the treatment of solid tumors. The lead therapy candidates in
preclinical development are targeting pancreatic cancer, mesothelioma, and ovarian cancer.
